Applied Therapeutics, Inc.
APLT
$0.441
-$0.0191-4.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -211.00K | -333.00K | -477.00K | 9.99M | 10.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -211.00K | -333.00K | -477.00K | 9.99M | 10.66M |
| Cost of Revenue | 90.95M | 86.91M | 88.79M | 92.51M | 94.24M |
| Gross Profit | -91.17M | -87.24M | -89.27M | -82.52M | -83.58M |
| SG&A Expenses | 39.72M | 29.39M | 24.11M | 20.62M | 22.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.07M | 77.70M | 74.30M | 74.53M | 73.16M |
| Operating Income | -92.28M | -78.04M | -74.77M | -64.54M | -62.50M |
| Income Before Tax | -187.31M | -161.09M | -193.56M | -119.76M | -96.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -187.31 | -161.09 | -193.56 | -119.76 | -96.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -187.31M | -161.09M | -193.56M | -119.76M | -96.51M |
| EBIT | -92.28M | -78.04M | -74.77M | -64.54M | -62.50M |
| EBITDA | -92.28M | -78.04M | -74.77M | -64.54M | -62.50M |
| EPS Basic | -1.47 | -1.46 | -1.85 | -1.36 | -1.31 |
| Normalized Basic EPS | -0.92 | -0.91 | -1.16 | -0.85 | -0.82 |
| EPS Diluted | -1.62 | -1.61 | -1.85 | -1.36 | -1.31 |
| Normalized Diluted EPS | -0.92 | -0.91 | -1.16 | -0.85 | -0.82 |
| Average Basic Shares Outstanding | 524.13M | 470.45M | 405.56M | 336.60M | 276.02M |
| Average Diluted Shares Outstanding | 532.59M | 478.91M | 405.56M | 336.60M | 276.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
